Financial Survey: Wellgistics Health (MEDS) versus Its Rivals

Wellgistics Health (NASDAQ:MEDS – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare Wellgistics Health to related companies based on the strength of its dividends, risk, valuation, institutional ownership, analyst recommendations, earnings and profitability.

Insider & Institutional Ownership

5.7% of Wellgistics Health shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 19.5% of Wellgistics Health shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Wellgistics Health has a beta of -3.13, suggesting that its share price is 413% less volatile than the S&P 500. Comparatively, Wellgistics Health’s competitors have a beta of 0.98, suggesting that their average share price is 2% less volatile than the S&P 500.

Profitability

This table compares Wellgistics Health and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Wellgistics Health -564.70% N/A -111.43%
Wellgistics Health Competitors -7.87% -135.89% -1.58%

Earnings & Valuation

This table compares Wellgistics Health and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Wellgistics Health $23.34 million -$101.28 million -0.01
Wellgistics Health Competitors $19.17 billion $301.67 million -1.63

Wellgistics Health’s competitors have higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Wellgistics Health and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wellgistics Health 1 0 0 0 1.00
Wellgistics Health Competitors 1879 7752 13387 833 2.55

As a group, “Healthcare Providers & Services” companies have a potential upside of 12.72%. Given Wellgistics Health’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Wellgistics Health has less favorable growth aspects than its competitors.

Summary

Wellgistics Health competitors beat Wellgistics Health on 10 of the 13 factors compared.

Wellgistics Health Company Profile

(Get Free Report)

Wellgistics Health is a U.S.-focused healthcare services and technology company centered on pharmaceutical distribution. It supplies prescription medicines, including branded and generic drugs, to pharmacies and other healthcare providers. The company also offers technology and services intended to support pharmacy purchasing, inventory management and connections among drug manufacturers, distributors and pharmacies. Its business is particularly oriented toward serving independent pharmacies. Wellgistics Health combines pharmaceutical wholesale distribution with technology-enabled pharmacy services.

Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.